CardiAMP™ Cell Therapy for Heart Failure Trial
Study sponsor: BioCardia, Inc. · BCDA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-02Actual
Enrollment · participants125Actual
Source updated2025-09-19Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.